AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Silo Pharma, Inc. Director's Dealing 2015

Jan 22, 2015

35304_dirs_2015-01-22_171ce083-cd4b-4b80-be25-b8aa00cbd67a.zip

Director's Dealing

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: Point Capital, Inc. (PTCI)
CIK: 0001514183
Period of Report: 2014-07-30

Reporting Person: Parker Walter Van Eps (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock	0	Direct

Footnotes

F1: 37,500 shares previously granted on 7/30/14 were subsequently rescinded in December 2014.